Publications by authors named "Yinxiang Hu"

Claim this Profile
M
MTHFD2 is required for DNA repair and implicated in LUAD radiotherapy resistance.
Qian Huang, Weiwei Ouyang, Shengfa Su, Zhu Ma, Yinxiang Hu

J Transl Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring mechanisms of radiation-induced myocardial fibrosis using HMGB1 neutralizing antibody.
Gang Wang, Bi-Bo Wu, Sha-Sha Zhao, Jing Zhang, Yu Wang, Yin-Xiang Hu

J Mol Histol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose radiation as a potential strategy for alleviating lung injury caused by radiotherapy combined with immunotherapy: A preclinical study.
Yu Wang, Jing Zhang, Yao Liu, Han Jiang, Bibo Wu, Yinxiang Hu

Radiother Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Method of Reducing Low-Dose Lung Volume in VMAT on Central Lung Cancer Planning].
Haojia Zhang, Yi Zhang, Haijie Jin, Shihu You, Jiaying Gan, Yinxiang Hu

Zhongguo Yi Liao Qi Xie Za Zhi· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis.
Bibo Wu, Shasha Zhao, Jing Zhang, Yao Liu, Jie Bai, Yinxiang Hu

Inflammation· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriate delay of primary tumour radiotherapy may lead to better long-term overall survival for non-small cell lung cancer treated with EGFR-TKIs.
Qingsong Li, Na Liang, Weiwei Ouyang, Shengfa Su, Zhu Ma, Yinxiang Hu, Huiqin Li

BMC Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer.
Mengfan Wang, Zhu Ma, Qingsong Li, Wengang Yang, Xiaxia Chen, Yinxiang Hu

Anticancer Drugs· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of thoracic tumor radiotherapy on survival in non-small-cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study.
Qingsong Li, Cheng Hu, Shengfa Su, Zhu Ma, Yichao Geng, Yinxiang Hu, Huiqin Li

Cancer Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy.
Qingsong Li, Cheng Hu, Shengfa Su, Zhu Ma, Yichao Geng, Yinxiang Hu, Huiqin Li

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury.
Jie Bai, Bibo Wu, Shasha Zhao, Gang Wang, Shengfa Su, Yinxiang Hu, Cheng Hu

J Inflamm Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment.
Qingsong Li, Cheng Hu, Shengfa Su, Zhu Ma, Yichao Geng, Yinxiang Hu, Huiqin Li

Cancer Manag Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change.
Qingsong Li, Na Liang, Xia Zhang, Yi Zhang, Weiwei Ouyang, Zhu Ma, Yinxiang Hu

Front Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Model to Predict Overall Survival for Metastatic Non-Small Cell Lung Cancer Patients Treated With Chemotherapy Combined With Concurrent Radiation Therapy to the Primary Tumor: Analysis From Two Prospective Studies.
Ling-Feng Liu, Qing-Song Li, Yin-Xiang Hu, Wen-Gang Yang, Xia-Xia Chen, Zhu Ma, Cheng Hu

Front Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous integrated boost of intensity-modulated radiation therapy to Stage II-III non-small cell lung cancer with metastatic lymph nodes.
Qing-Song Li, Na Liang, Wei-Wei Ouyang, Sheng-Fa Su, Zhu Ma, Yin-Xiang Hu, Hui-Qin Li

Cancer Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of pemetrexed-cisplatin or docetaxel-cisplatin plus thoracic intensity-modulated radiation therapy in patients with stage IV lung adenocarcinoma.
Sheng-Fa Su, Mei Li, Yi-Chao Geng, Wen-Gang Yang, Zhu Ma, Yin-Xiang Hu

Am J Cancer Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positioning error and expanding margins of planning target volume with kilovoltage cone beam computed tomography for prostate cancer radiotherapy.
Gang Wang, Wen-Ling Wang, Yi-Qun Liu, Hong-Min Dong, Yin-Xiang Hu

Onco Targets Ther· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies.
ShengFa Su, YinXiang Hu, WeiWei Ouyang, Zhu Ma, QingSong Li, HuiQin Li, XiaoHu Wang

BMC Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
ShengFa Su, Tao Li, Bing Lu, XiaoHu Wang, JianCheng Li, YinXiang Hu, Zhu Ma, HuiQin Li

Int J Radiat Oncol Biol Phys· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy.
ShengFa Su, YinXiang Hu, WeiWei Ouyang, Zhu Ma, Bing Lu, HuiQin Li

Radiat Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: reanalysis of the findings of a single-center prospective study.
Wei-Wei Ouyang, Sheng-Fa Su, Yin-Xiang Hu, Bing Lu, Zhu Ma, Hui-Qin Li

BMC Cancer· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy.
Wei-Wei Ouyang, Sheng-Fa Su, Zhu Ma, Yin-Xiang Hu, Bing Lu, Hui-Qin Li

Radiat Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.
Sheng-Fa Su, Yin-Xiang Hu, Wei-Wei Ouyang, Bing Lu, Zhu Ma, Hui-Qin Li

BMC Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis